Recombinant human IFN- administered as a therapy for chronic viral hepatitis and malignancy is thought to cause em de novo /em SLE in some patients [6]

Recombinant human IFN- administered as a therapy for chronic viral hepatitis and malignancy is thought to cause em de novo

Continue readingRecombinant human IFN- administered as a therapy for chronic viral hepatitis and malignancy is thought to cause em de novo /em SLE in some patients [6]

Unfortunately, these methods entail eventual inconveniences that limit the practical usefulness of the tagging deletion such as: (a) an excessive attenuation and/or loss of vaccine efficacy (Barrio et?al

Unfortunately, these methods entail eventual inconveniences that limit the practical usefulness of the tagging deletion such as: (a) an excessive

Continue readingUnfortunately, these methods entail eventual inconveniences that limit the practical usefulness of the tagging deletion such as: (a) an excessive attenuation and/or loss of vaccine efficacy (Barrio et?al